Endpoints Capital was founded to address the funding challenges that biotechnology companies face by providing a financing solution that benefits biotechs at all stages. We understand the life sciences ecosystem and the challenges - including financing - that biotech companies face getting their treatment or device into the clinic. This has been further compounded by the difficulties in capital markets in recent times.We are excited by the opportunity to help biotechs accelerate their discovery of new medicines, therapies and life changing treatments.